Published in Am J Hum Genet on April 15, 2010
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine (DCS) | NCT02304432
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders | NCT01720316
Genome structural variation discovery and genotyping. Nat Rev Genet (2011) 7.34
Genomics, intellectual disability, and autism. N Engl J Med (2012) 3.74
Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet (2013) 3.65
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet (2013) 3.64
Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet (2010) 2.57
Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. Lancet Neurol (2014) 2.25
Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet (2011) 1.94
Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol (2011) 1.88
A roadmap for precision medicine in the epilepsies. Lancet Neurol (2015) 1.75
Copy number variation plays an important role in clinical epilepsy. Ann Neurol (2014) 1.73
Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet (2012) 1.72
Performance of genotype imputation for rare variants identified in exons and flanking regions of genes. PLoS One (2011) 1.72
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
Epilepsy genetics--past, present, and future. Curr Opin Genet Dev (2011) 1.46
Ethical challenges in genotype-driven research recruitment. Genome Res (2010) 1.26
Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders. PLoS One (2013) 1.23
The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet (2012) 1.23
Using ERDS to infer copy-number variants in high-coverage genomes. Am J Hum Genet (2012) 1.22
Epi4K: gene discovery in 4,000 genomes. Epilepsia (2012) 1.21
Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies. PLoS Genet (2015) 1.20
Epilepsy and the new cytogenetics. Epilepsia (2011) 1.19
Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia (2012) 1.17
Neurogenetics: advancing the "next-generation" of brain research. Neuron (2010) 1.16
The genetics of microdeletion and microduplication syndromes: an update. Annu Rev Genomics Hum Genet (2014) 1.16
Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur J Hum Genet (2011) 1.07
Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet (2010) 1.06
Clinical review: Genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed. J Clin Endocrinol Metab (2012) 1.04
Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy. PLoS Genet (2013) 1.00
Genetically complex epilepsies, copy number variants and syndrome constellations. Genome Med (2010) 0.98
Advancing epilepsy genetics in the genomic era. Genome Med (2015) 0.97
Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J Am Acad Child Adolesc Psychiatry (2014) 0.96
NDE1 and NDEL1: twin neurodevelopmental proteins with similar 'nature' but different 'nurture'. Biomol Concepts (2013) 0.95
Prioritization of epilepsy associated candidate genes by convergent analysis. PLoS One (2011) 0.92
Genome-wide copy number analysis uncovers a new HSCR gene: NRG3. PLoS Genet (2012) 0.90
Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an 'exome-first' approach. J Hum Genet (2015) 0.89
Copy number variants: a new molecular frontier in clinical psychiatry. Curr Psychiatry Rep (2011) 0.89
A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk. Hum Mol Genet (2012) 0.89
Distribution of disease-associated copy number variants across distinct disorders of cognitive development. J Am Acad Child Adolesc Psychiatry (2013) 0.88
Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome. Hum Genet (2015) 0.87
Copy number variation in patients with cervical artery dissection. Eur J Hum Genet (2012) 0.87
Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions. PLoS One (2011) 0.87
Neuropathology of 16p13.11 deletion in epilepsy. PLoS One (2012) 0.86
A genomic copy number variant analysis implicates the MBD5 and HNRNPU genes in Chinese children with infantile spasms and expands the clinical spectrum of 2q23.1 deletion. BMC Med Genet (2014) 0.86
Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruption. Am J Med Genet A (2013) 0.85
Genetic forms of epilepsies and other paroxysmal disorders. Semin Neurol (2014) 0.84
Atypical face shape and genomic structural variants in epilepsy. Brain (2012) 0.84
Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. Hum Mutat (2012) 0.83
Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? Mol Autism (2013) 0.83
Canine epilepsy genetics. Mamm Genome (2011) 0.83
CNVs in Epilepsy. Curr Genet Med Rep (2014) 0.83
Describing the genetic architecture of epilepsy through heritability analysis. Brain (2014) 0.82
Genetic variations and associated pathophysiology in the management of epilepsy. Appl Clin Genet (2011) 0.82
Clinical Genetic Testing in Epilepsy. Epilepsy Curr (2015) 0.82
Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility. Schizophr Bull (2014) 0.81
SNP arrays: comparing diagnostic yields for four platforms in children with developmental delay. BMC Med Genomics (2014) 0.81
Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia. Front Cell Neurosci (2015) 0.81
Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery. Epilepsia (2011) 0.81
The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation. Elife (2014) 0.80
Array comparative genomic hybridization: results from an adult population with drug-resistant epilepsy and co-morbidities. Eur J Med Genet (2012) 0.80
SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res (2013) 0.79
The expression and roles of Nde1 and Ndel1 in the adult mammalian central nervous system. Neuroscience (2014) 0.79
Genome-wide signatures of 'rearrangement hotspots' within segmental duplications in humans. PLoS One (2011) 0.78
Advances in epilepsy genetics and genomics. Epilepsy Curr (2012) 0.78
Structural genomic variation in childhood epilepsies with complex phenotypes. Eur J Hum Genet (2013) 0.78
6q22.1 microdeletion and susceptibility to pediatric epilepsy. Eur J Hum Genet (2014) 0.77
Growth of genome screening needs debate. Nature (2011) 0.77
Modifier genetics in neuropsychiatric disease: challenges and opportunities. Genome Biol (2012) 0.77
Clinical utility gene card for: 16p13.11 microdeletion syndrome. Eur J Hum Genet (2013) 0.76
Co-occurrence of 16p13.11 microdeletion and ring chromosome 20 syndrome. Neurol Genet (2016) 0.75
Finding the Missing Pieces: The Microdeletion Burden in GGE. Epilepsy Curr (2016) 0.75
Concomitant deletion of chromosome 16p13.11 and triplication of chromosome 19p13.3 in a child with developmental disorders, intellectual disability, and epilepsy. Mol Cytogenet (2015) 0.75
Quantitative magnetic resonance imaging traits as endophenotypes for genetic mapping in epilepsy. Neuroimage Clin (2016) 0.75
When Should Genetic Testing Be Performed in Epilepsy Patients? Epilepsy Curr (2017) 0.75
Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy. BMC Med Genet (2016) 0.75
Identifying CNVs in 15q11q13 and 16p11.2 of Patients with Seizures Increases the Rates of Detecting Pathogenic Changes. Mol Syndromol (2016) 0.75
Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: Two case reports. Am J Med Genet A (2016) 0.75
GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant. Neurobiol Dis (2017) 0.75
Genetic and epigenetic mechanisms of epilepsy: a review. Neuropsychiatr Dis Treat (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med (2008) 19.71
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88
15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet (2001) 3.83
Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet (2002) 3.73
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet (2008) 3.35
Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet (2002) 2.72
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet (2002) 2.65
Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.32
Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet (2009) 2.12
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84
A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol (2002) 1.77
Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci U S A (2009) 1.73
Lis1-Nde1-dependent neuronal fate control determines cerebral cortical size and lamination. Hum Mol Genet (2008) 1.45
Psychiatric comorbidities in epilepsy. Int Rev Neurobiol (2008) 1.41
A novel GABRG2 mutation associated with febrile seizures. Neurology (2006) 1.41
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. Epilepsy Res (2008) 1.04
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet (2008) 30.94
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
Rare variants create synthetic genome-wide associations. PLoS Biol (2010) 14.43
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet (2010) 9.53
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10
Discerning the ancestry of European Americans in genetic association studies. PLoS Genet (2007) 7.81
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16
WGAViewer: software for genomic annotation of whole genome association studies. Genome Res (2008) 7.15
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol (2011) 6.77
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol (2008) 6.76
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology (2010) 6.14
A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet (2005) 5.81
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A (2003) 5.77
Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Curr Biol (2002) 5.58
Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet (2013) 5.58
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol (2008) 5.08
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci (2006) 4.87
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature (2010) 4.64
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60
Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet (2003) 4.58
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp (2003) 4.34
Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet (2010) 4.29
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet (2009) 4.11
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain (2009) 4.01
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med (2011) 3.93
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92